EDGAR Filing Documents for 0001193125-21-013638

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001193125-21-013638

Filing Date

2021-01-21

Accepted

2021-01-21 17:04:22

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	d12418d424b5.htm	424B5	477383
2	GRAPHIC	g12418g01t89.jpg	GRAPHIC	42886
3	GRAPHIC	g12418g06l50.jpg	GRAPHIC	138710
4	GRAPHIC	g12418g52e35.jpg	GRAPHIC	38119
	Complete submission text file	0001193125-21-013638.txt		763622

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-228203 | Film No.: 21542762
SIC: 2834 Pharmaceutical Preparations